Home>Topics>Insider Trading

Insider Trading

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
  1. We've scheduled your meeting but don't think for a minute that we've given up the fight

    Headlines

    Tue, 26 Aug 2014

    injunction against Valeant Pharmaceuticals ( VRX +1.4% ) and Pershing Square Capital Management for violating insider trading laws. If successful, the pursuers will be blocked from counting their AGN shares in the total used to call the special

  2. UPDATE 2-U.S. charges investor relations executive with insider trading

    Headlines

    Tue, 26 Aug 2014

    (Adds details of investigation, bail hearing and comment from firm founder)

  3. UPDATE 1-U.S. charges investor relations firm employee with insider trading

    Headlines

    Tue, 26 Aug 2014

    (Adds details of separate SEC civil charges, prosecutor comment, case citation)

  4. U.S. charges investor relations firm employee with insider trading

    Headlines

    Tue, 26 Aug 2014

    NEW YORK, Aug 26 (Reuters) - An employee of a New York investor relations firm was charged with insider trading on Tuesday, after federal authorities accused him of using nonpublic information to earn more than $538,000 in illicit profits.

  5. Leucadia backs SAC alum''s hedge fund

    Headlines

    Tue, 26 Aug 2014

    be led Sol Kumin, the COO of Steven Cohen's SAC from 2008 to January 2014. While SAC last year plead guilty to insider trading and eight employees were found guilty of similar charges, Kumin himself was never accused of any wrongdoing. Leucadia

  6. Former Qualcomm executive pleads guilty to insider trading

    Headlines

    Fri, 22 Aug 2014

    Aug 22 (Reuters) - A former Qualcomm Inc sales director has pleaded guilty to insider trading in Atheros Communications Inc after learning that his company planned to buy the rival chipmaker in 2011.

  7. U.S. court blocks Allergan's request to accelerate lawsuit

    Headlines

    Fri, 22 Aug 2014

    NYSE: VRX ) and Pershing Square has been denied by a California federal judge. Allergan claims the two engaged in insider trading ahead of their takeover bid, saying their unusual partnership violated securities regulations. Pershing Square

  8. U.S. court denies Allergan bid to speed insider trading suit

    Headlines

    Thu, 21 Aug 2014

    (Reuters) - A federal judge in California on Thursday denied a request by Allergan Inc to expedite its civil suit claiming that Valeant Pharmaceuticals International Inc and Pershing Square Capital Management engaged in insider trading ahead of their bid to buy Allergan.

  9. U.S. court denies Allergan bid to speed insider trading suit

    Headlines

    Thu, 21 Aug 2014

    (Reuters) - A federal judge in California on Thursday denied a request by Allergan Inc to expedite its civil suit claiming that Valeant Pharmaceuticals International Inc and Pershing Square Capital Management engaged in insider trading ahead of their bid to buy Allergan.

  10. UPDATE 1-U.S. court denies Allergan bid to speed insider trading suit

    Headlines

    Thu, 21 Aug 2014

    Aug 21 (Reuters) - A federal judge in California on Thursday denied a request by Allergan Inc to expedite its civil suit claiming that Valeant Pharmaceuticals International Inc and Pershing Square Capital Management engaged in insider trading ahead of their bid to buy Allergan.

« Prev12345Next »
Content Partners